271 related articles for article (PubMed ID: 33980914)
1. A comprehensive retrospective cohort study of the journey of B-cell lymphoma in Taiwan.
Pei SN; Wang MC; Ma MC; Kuo CY; Liao CK; Qiu H; Rothwell LA; Liu Y
Sci Rep; 2021 May; 11(1):10069. PubMed ID: 33980914
[TBL] [Abstract][Full Text] [Related]
2. Diffuse large B-cell lymphoma and mantle cell lymphoma of the ocular adnexal region, and lymphoma of the lacrimal gland: an investigation of clinical and histopathological features.
Rasmussen PK
Acta Ophthalmol; 2013 Jul; 91 Thesis 5():1-27. PubMed ID: 24041159
[TBL] [Abstract][Full Text] [Related]
3. Conjunctival Lymphoma--An International Multicenter Retrospective Study.
Kirkegaard MM; Rasmussen PK; Coupland SE; Esmaeli B; Finger PT; Graue GF; Grossniklaus HE; Honavar SG; Khong JJ; McKelvie PA; Mulay K; Prause JU; Ralfkiaer E; Sjö LD; Toft PB; Vemuganti GK; Thuro BA; Curtin J; Heegaard S
JAMA Ophthalmol; 2016 Apr; 134(4):406-14. PubMed ID: 26891973
[TBL] [Abstract][Full Text] [Related]
4. Racial differences in three major NHL subtypes: descriptive epidemiology.
Li Y; Wang Y; Wang Z; Yi D; Ma S
Cancer Epidemiol; 2015 Feb; 39(1):8-13. PubMed ID: 25560974
[TBL] [Abstract][Full Text] [Related]
5. The impact of rheumatological disorders on lymphomas and myeloma: a report on risk and survival from the UK's population-based Haematological Malignancy Research Network.
Kane E; Painter D; Smith A; Crouch S; Oliver S; Patmore R; Roman E
Cancer Epidemiol; 2019 Apr; 59():236-243. PubMed ID: 30844679
[TBL] [Abstract][Full Text] [Related]
6. Phase 2 Study of Daratumumab in Relapsed/Refractory Mantle-Cell Lymphoma, Diffuse Large B-Cell Lymphoma, and Follicular Lymphoma.
Salles G; Gopal AK; Minnema MC; Wakamiya K; Feng H; Schecter JM; Wang M
Clin Lymphoma Myeloma Leuk; 2019 May; 19(5):275-284. PubMed ID: 30795996
[TBL] [Abstract][Full Text] [Related]
7. Orbital Lymphoma-An International Multicenter Retrospective Study.
Olsen TG; Holm F; Mikkelsen LH; Rasmussen PK; Coupland SE; Esmaeli B; Finger PT; Graue GF; Grossniklaus HE; Honavar SG; Khong JJ; McKelvie PA; Mulay K; Sjö LD; Vemuganti GK; Thuro BA; Heegaard S
Am J Ophthalmol; 2019 Mar; 199():44-57. PubMed ID: 30419193
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathological features of splenic tumours of lymphoid tissue.
Chen DB; Shen DH; Yang SM; Fang XZ
Pathol Res Pract; 2018 Dec; 214(12):1952-1958. PubMed ID: 30087035
[TBL] [Abstract][Full Text] [Related]
9. Cardiovascular mortality among patients with non-Hodgkin lymphoma: Differences according to lymphoma subtype.
Abuamsha H; Kadri AN; Hernandez AV
Hematol Oncol; 2019 Aug; 37(3):261-269. PubMed ID: 30916804
[TBL] [Abstract][Full Text] [Related]
10. Ocular adnexal lymphoma in Denmark: a nationwide study of 387 cases from 1980 to 2017.
Holm F; Mikkelsen LH; Kamper P; Rasmussen PK; Larsen TS; Sjö LD; Heegaard S
Br J Ophthalmol; 2021 Jul; 105(7):914-920. PubMed ID: 32732342
[TBL] [Abstract][Full Text] [Related]
11. An open-label phase 2 trial of entospletinib in indolent non-Hodgkin lymphoma and mantle cell lymphoma.
Andorsky DJ; Kolibaba KS; Assouline S; Forero-Torres A; Jones V; Klein LM; Patel-Donnelly D; Smith M; Ye W; Shi W; Yasenchak CA; Sharman JP
Br J Haematol; 2019 Jan; 184(2):215-222. PubMed ID: 30183069
[TBL] [Abstract][Full Text] [Related]
12. Non-Hodgkin lymphomas: impact of rituximab on overall survival of patients with diffuse large B-cell and follicular lymphoma.
Jaime-Pérez JC; Gamboa-Alonso CM; Vázquez-Mellado de Larracoechea A; Rodríguez-Martínez M; Gutiérrez-Aguirre CH; Marfil-Rivera LJ; Gómez-Almaguer D
Arch Med Res; 2015 Aug; 46(6):454-61. PubMed ID: 26235285
[TBL] [Abstract][Full Text] [Related]
13. Improving survival of 3760 patients with lymphoma: Experience of an academic center over two decades.
Liu W; Ji X; Song Y; Wang X; Zheng W; Lin N; Tu M; Xie Y; Ping L; Ying Z; Zhang C; Deng L; Wu M; Feng F; Leng X; Sun Y; Du T; Zhu J
Cancer Med; 2020 Jun; 9(11):3765-3774. PubMed ID: 32281275
[TBL] [Abstract][Full Text] [Related]
14. [Clinical Features and Outcomes of the Patients with B-Cell Chronic Lymphoproliferative Disease in the New Drug Era].
Xu CB; Hu M; Shen JZ; Xu HQ; Zheng RJ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Jun; 31(3):722-729. PubMed ID: 37356932
[TBL] [Abstract][Full Text] [Related]
15. Long-term Follow-up of Patients with Relapsed or Refractory Non-Hodgkin Lymphoma Treated with Venetoclax in a Phase I, First-in-Human Study.
Davids MS; Roberts AW; Kenkre VP; Wierda WG; Kumar A; Kipps TJ; Boyer M; Salem AH; Pesko JC; Arzt JA; Mantas M; Kim SY; Seymour JF
Clin Cancer Res; 2021 Sep; 27(17):4690-4695. PubMed ID: 34083230
[TBL] [Abstract][Full Text] [Related]
16. Lipid Trait Variants and the Risk of Non-Hodgkin Lymphoma Subtypes: A Mendelian Randomization Study.
Kleinstern G; Camp NJ; Berndt SI; Birmann BM; Nieters A; Bracci PM; McKay JD; Ghesquières H; Lan Q; Hjalgrim H; Benavente Y; Monnereau A; Wang SS; Zhang Y; Purdue MP; Zeleniuch-Jacquotte A; Giles GG; Vermeulen R; Cocco P; Albanes D; Teras LR; Brooks-Wilson AR; Vajdic CM; Kane E; Caporaso NE; Smedby KE; Salles G; Vijai J; Chanock SJ; Skibola CF; Rothman N; Slager SL; Cerhan JR
Cancer Epidemiol Biomarkers Prev; 2020 May; 29(5):1074-1078. PubMed ID: 32108027
[TBL] [Abstract][Full Text] [Related]
17. Ibrutinib: first global approval.
Cameron F; Sanford M
Drugs; 2014 Feb; 74(2):263-71. PubMed ID: 24464309
[TBL] [Abstract][Full Text] [Related]
18. MNDA expression and its value in differential diagnosis of B-cell non-Hodgkin lymphomas: a comprehensive analysis of a large series of 1293 cases.
Zhang LF; Zhang Y; Shui RH; Lu HF; Jiang WH; Cai X; Li XQ; Yu BH
Diagn Pathol; 2024 Apr; 19(1):60. PubMed ID: 38627702
[TBL] [Abstract][Full Text] [Related]
19. [Immunohistochemical patterns of follicular dendritic cell meshwork and Ki-67 in small B-cell lymphomas].
Shi YF; Li XH
Zhonghua Bing Li Xue Za Zhi; 2013 Apr; 42(4):222-6. PubMed ID: 23928527
[TBL] [Abstract][Full Text] [Related]
20. Non-Hodgkin lymphoma subtype distribution, geodemographic patterns, and survival in the US: A longitudinal analysis of the National Cancer Data Base from 1998 to 2011.
Al-Hamadani M; Habermann TM; Cerhan JR; Macon WR; Maurer MJ; Go RS
Am J Hematol; 2015 Sep; 90(9):790-5. PubMed ID: 26096944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
